Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Nonselective Beta Blocker vs Placebo in Patients With Acute-on-chronic Liver Failure With Small/ no Esophageal Varices

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Acute on Chronic Liver Failure as per APASL (Asian Pacific Association of Study of Liver Disease) criteria.~2. 18-75 years~3. HVPG ≥ 12 + No/Small Esophageal varices~Exclusion Criteria:~1. Bradycardia (HR \< 60/ min)~2. Hypotension~3. Asthma~4. LVF~5. AKI (Acute Kidney Injury), (S.creat \>1.5)~6. Refractory ascites~7. SBP (Spontaneous Bacterial Peritonitis)~8. Pregnancy or Lactation~9. Past history of EVL or EST~10. Significant cardio - pulmonary co-morbidity~11. PVT~12. Presence of grades 3-4 hepatic encephalopathy (HE)~13. Patients going for liver transplant in next 12 weeks~14. No consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Carvedilol (Type: EXPERIMENTAL): Tab Carvedilol 3.125 mg twice daily followed by 6.25 mg BD and finally 12.5 mg BD if SBP \> 90 mmHg and HR \>55/min
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).